LISCure Biosciences Inc.
PrivateLast Round
Private Equity
Jan 10, 2025
Est. Valuation
$80.6M
Total Funding Raised
$43.54M
Company Overview
LISCure Biosciences Inc. is a clinical-stage biotechnology company that develops bacteria-mediated cancer immunotherapy and oral microbiome therapeutics for oncology, liver diseases, neuroscience, and immunology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LISCure Biosciences Inc. Comparables
Compare LISCure Biosciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exeliom Biosciences | 80% | |
| EnteroBiotix | 78% | |
| MRM Health | 77% | |
LISCure Biosciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jan 10, 2025 | ||||
| Strategic | Aug 1, 2021 | ||||
| Series B | Feb 25, 2021 | ||||
| Strategic | Dec 11, 2020 | ||||
| Strategic | Oct 28, 2020 | ||||
Strategic | Oct 21, 2020 |
Key People
Founding team and executive leadership
LISCure Biosciences Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IGIS Asset Management | Private Equity |
| KB Securities | Seed |
| Dt& Investment | Private Equity |
| Shinhan Securities | Seed |
| Yuanta Investment | Private Equity |
| InterValue Partners | Private Equity |
| NHN Investment | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2021
Mayo Clinic participated in the strategic round.
- Jul 25, 2019
$5M raised from KB Securities, Shinhan Securities, and NHN Investment.
LISCure Biosciences Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LISCure Biosciences Inc.'s valuation, stock price, and market status.